Chemoinformaics analysis of gamma-L-Glutamyl-L-cysteinyl-beta-alanine
Molecular Weight | 320.347 | nRot | 10 |
Heavy Atom Molecular Weight | 302.203 | nRig | 4 |
Exact Molecular Weight | 320.092 | nRing | 0 |
Solubility: LogS | -1.278 | nHRing | 0 |
Solubility: LogP | -3.593 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 7 | APOL | 41.3843 |
nHD | 4 | BPOL | 25.7257 |
QED | 0.258 |
Synth | 2.982 |
Natural Product Likeliness | 0.323 |
NR-PPAR-gamma | 0.024 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.101 |
HIA | 0.258 |
CACO-2 | -6.758 |
MDCK | 0.000625895 |
BBB | 0.1 |
PPB | 0.118026 |
VDSS | 0.386 |
FU | 0.878007 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.009 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.031 |
CYP2c9-inh | 0.136 |
CYP2c9-sub | 0.533 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.121 |
CYP3a4-inh | 0.01 |
CYP3a4-sub | 0.002 |
CL | 2.805 |
T12 | 0.847 |
hERG | 0.007 |
Ames | 0.862 |
ROA | 0.015 |
SkinSen | 0.121 |
Carcinogencity | 0.038 |
EI | 0.029 |
Respiratory | 0.06 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.63622 |